Immuneering logo

Immuneering Share Price Today

(NASDAQ: IMRX)

Immuneering share price is $1.5 & ₹130.45 as on 6 Mar 2025, 2.30 'hrs' IST

$1.5

0.02

(1.35%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Immuneering share price in Dollar and Rupees. Guide to invest in Immuneering stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immuneering, along with analyst recommendations, forecasts, and comprehensive financials.

Immuneering share price movements

  • Today's Low: $1.46
    Today's High: $1.51

    Day's Volatility :3.31%

  • 52 Weeks Low: $1.00
    52 Weeks High: $6.78

    52 Weeks Volatility :85.25%

Immuneering (IMRX) Returns

PeriodImmuneering CorpIndex (Russel 2000)
3 Months
-30.84%
0.0%
6 Months
24.37%
0.0%
1 Year
-76.87%
0.0%
3 Years
-77.51%
-11.6%

Immuneering (IMRX) Key Statistics

in dollars & INR

Previous Close
$1.48
Open
$1.475
Today's High
$1.51
Today's Low
$1.46
Market Capitalization
$46.0M
Today's Volume
$10.0K
52 Week High
$6.78
52 Week Low
$1.0
Revenue TTM
$455.0
EBITDA
$-61.4M
Earnings Per Share (EPS)
$-1.98
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-71.81%

How to invest in Immuneering Stock (IMRX) from India?

It is very easy for Indian residents to invest directly in Immuneering from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immuneering stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immuneering or IMRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immuneering or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immuneering shares which would translate to 0.580 fractional shares of Immuneering as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immuneering, in just a few clicks!

Returns in Immuneering (IMRX) for Indian investors in Rupees

The Immuneering stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immuneering investment value today

Current value as on today

₹28,400

Returns

₹71,600

(-71.6%)

Returns from Immuneering Stock

₹76,563 (-76.56%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Immuneering (IMRX)

-90%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Immuneering Stock from India on INDmoney has decreased by -90% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Immuneering

  • Vanguard Group Inc

    3.40%

  • T. Rowe Price Associates, Inc.

    2.47%

  • Morgan Stanley - Brokerage Accounts

    1.46%

  • BlackRock Inc

    1.03%

  • SOUTHPORT MANAGEMENT, L.L.C.

    0.69%

  • Geode Capital Management, LLC

    0.67%

Analyst Recommendation on Immuneering

Buy

    71%Buy

    28%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Immuneering(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
13
Hold
4
5
2
Sell
0
0
0

Analyst Forecast on Immuneering Stock (IMRX)

What analysts predicted

Upside of 694.45%

Target:

$11.92

Current:

$1.50

Insights on Immuneering Stock (Ticker Symbol: IMRX)

  • Price Movement

    In the last 1 year, IMRX stock has moved down by -76.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 94.41M → -94.41M (in $), with an average decrease of 200.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -14.07M → -14.59M (in $), with an average decrease of 3.7% per quarter
  • IMRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 138.4%
  • IMRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 125.4%

Immuneering Technicals Summary

Sell

Neutral

Buy

Immuneering is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Immuneering (IMRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Immuneering Corp logo
-21.28%
24.37%
-76.87%
-77.51%
-91.59%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Immuneering Corp logo
NA
NA
NA
-1.82
-0.72
-0.42
NA
1.86
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Immuneering Corp logo
Buy
$46.0M
-91.59%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Immuneering

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Organization
Immuneering
Employees
66
CEO
Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Industry
Miscellaneous

Management People of Immuneering

NameTitle
Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Co-Founder, President, CEO & Director
Mr. Robert J. Carpenter M.B.A., M.S.
Co-Founder & Chair Emeritus
Dr. Brett M. Hall Ph.D.
Chief Scientific Officer
Mr. Harold E. Brakewood
Chief Business Officer
Ms. Mallory Morales CPA
Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer
Ms. Paula George CPA
Director of Accounting & Operations and Assistant Corporate Controller
Mr. Michael D. Bookman J.D.
Chief Legal Officer & Secretary
Ms. Leah R. Neufeld
Chief People Officer
Dr. Peter King Ph.D.
Head of Discovery & VP
Dr. Praveen Nair Ph.D.
Head of Translational Pharmacology & VP

Important FAQs about investing in IMRX Stock from India :

What is Immuneering share price today?

Immuneering share price today stands at $1.50, Open: $1.48 ; Previous Close: $1.48 ; High: $1.51 ; Low: $1.46 ; 52 Week High: $6.78 ; 52 Week Low: $1.00.

The stock opens at $1.48, after a previous close of $1.48. The stock reached a daily high of $1.51 and a low of $1.46, with a 52-week high of $6.78 and a 52-week low of $1.00.

Can Indians buy Immuneering shares?

Yes, Indians can invest in the Immuneering (IMRX) from India.

With INDmoney, you can buy Immuneering at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Immuneering at zero transaction cost.

How can I buy Immuneering shares from India?

It is very easy to buy Immuneering from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immuneering (IMRX) be purchased?

Yes, you can buy fractional shares of Immuneering with INDmoney app.

What are the documents required to start investing in Immuneering stocks?

To start investing in Immuneering, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Immuneering Stock (IMRX)?

Today’s highest price of Immuneering (IMRX) is $1.51.

Today’s lowest price of Immuneering (IMRX) is $1.46.

What is today's market capitalisation of Immuneering?

Today's market capitalisation of Immuneering IMRX is 46.0M

What is the 52 Week High and Low Range of Immuneering Stock (IMRX)?

  • 52 Week High

    $6.78

  • 52 Week Low

    $1.00

What are the historical returns of Immuneering (IMRX)?

  • 1 Month Returns

    -21.28%

  • 3 Months Returns

    24.37%

  • 1 Year Returns

    -76.87%

  • 5 Years Returns

    -91.59%

Who is the Chief Executive Officer (CEO) of Immuneering ?

Dr. Benjamin J. Zeskind M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Immuneering.